succinylcholine has been researched along with Diathesis in 27 studies
Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The literature is briefly reviewed and an account of the present status of malignant hyperthermia (porcine stress syndrome) in Ontario boars using the halothane or halothane/succinylcholine screening tests is presented." | 7.66 | Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars. ( Basrur, PK; McDonell, WN; Seeler, DC, 1983) |
| "(1) To investigate changes in arterial oxygen saturation via pulse oximeter (SpO2) during apnea and after reinstitution of manual ventilation at SpO2 of 95% or 90% following rapid sequence induction of anesthesia in children after 2-minute preoxygenation; (2) to determine whether the setting of a safe threshold of apneic period to an SpO2 of 95% is appropriate in children during anesthetic induction; and (3) to evaluate the influences of age, body weight, and height on the time from the start of apnea to SpO2 of 95%." | 5.08 | Study of the safe threshold of apneic period in children during anesthesia induction. ( An, G; Deng, XM; Liao, X; Luo, LK; Tong, SY; Xue, FS, 1996) |
| " However, experts worldwide agree that the only reference test to this day remains the in vitro halothane caffeine contracture tests." | 4.77 | [Screening tests for malignant hyperthermia susceptibility]. ( Adnet, P; Krivosic-Horber, R, 1989) |
| " The literature is briefly reviewed and an account of the present status of malignant hyperthermia (porcine stress syndrome) in Ontario boars using the halothane or halothane/succinylcholine screening tests is presented." | 3.66 | Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars. ( Basrur, PK; McDonell, WN; Seeler, DC, 1983) |
| "Masseter spasm is often associated with severe rhabdomyolysis in patients with muscle dystrophy, especially Duchenne's dystrophy." | 2.38 | [Clinical features of malignant hyperthermia crisis]. ( Cornet, C; Laxenaire, MC; Moeller, R, 1989) |
| "This contracture is not prevented or relieved by regional anaesthesia or muscle relaxants." | 2.38 | [Anesthesia in myotonia]. ( Lienhart, A, 1989) |
| "To investigate a possible link of malignant hyperthermia to capture myopathy, between June 1990 and July 1993 we anesthetized four black-tailed deer (Odocoileus hemionus columbianus) and challenged them with halothane and succinylcholine." | 1.29 | Evaluation for malignant hyperthermia susceptibility in black-tailed deer. ( Antognini, JF; Eisele, PH; Gronert, GA, 1996) |
| "When muscle spasm is induced with suxamethonium, malignant hyperpyrexia must be considered a probable diagnosis." | 1.27 | Suxamethonium spasm. A differential diagnostic conundrum. ( Ellis, FR; Halsall, PJ, 1984) |
| "in an attempt to induce malignant hyperthermia." | 1.27 | Failure to induce malignant hyperthermia in myotonic goats. ( Gronert, GA; Lambert, EH; Newberg, LA, 1983) |
| "Malignant hyperthermia is a seemingly rare genetic myopathy." | 1.27 | Malignant hyperthermia in plastic surgery. ( Abdul-Rasool, IH; Dubrow, TJ; Lesavoy, MA; Wackym, PA, 1988) |
| "The familial nature of anaesthetic malignant hyperthermia must lead to the search for susceptibility in other members of the family of a sensitive subject." | 1.27 | [Examination of the family of a patient susceptible to anesthetic malignant hyperthermia]. ( Adnet, P; Guévart, E; Krivosic, I; Krivosic-Horber, R; Theunynck, D, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (55.56) | 18.7374 |
| 1990's | 9 (33.33) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 1 (3.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Metterlein, T | 1 |
| Schuster, F | 1 |
| Palmer, E | 1 |
| Roewer, N | 2 |
| Anetseder, M | 1 |
| Claxton, BA | 1 |
| Cross, MH | 1 |
| Hopkins, PM | 1 |
| Seeler, DC | 1 |
| McDonell, WN | 1 |
| Basrur, PK | 1 |
| Ellis, FR | 1 |
| Halsall, PJ | 1 |
| Newberg, LA | 1 |
| Lambert, EH | 1 |
| Gronert, GA | 3 |
| Rosenberg, H | 5 |
| Fletcher, JE | 5 |
| Calvo, PA | 1 |
| Xue, FS | 1 |
| Luo, LK | 1 |
| Tong, SY | 1 |
| Liao, X | 1 |
| Deng, XM | 1 |
| An, G | 1 |
| Antognini, JF | 1 |
| Eisele, PH | 2 |
| Goresky, GV | 1 |
| Cox, RG | 1 |
| Kadar, AG | 1 |
| Kramer, BA | 1 |
| Barth, MC | 1 |
| White, PF | 1 |
| Cosgrove, SB | 1 |
| Martucci, RW | 1 |
| Jantzen, JP | 1 |
| Eberle, B | 1 |
| Gaida, BJ | 1 |
| Hennes, HJ | 1 |
| Otto, S | 1 |
| Schäfer, M | 1 |
| Scholz, J | 1 |
| Rum, U | 1 |
| Schmitz, W | 1 |
| Scholz, H | 1 |
| Schulte am Esch, J | 1 |
| Aitken, HA | 1 |
| Howie, JC | 1 |
| Guerreiro, JF | 1 |
| Santos, SE | 1 |
| Aguiar, GF | 1 |
| Cornet, C | 1 |
| Moeller, R | 1 |
| Laxenaire, MC | 1 |
| Lienhart, A | 1 |
| Krivosic-Horber, R | 2 |
| Adnet, P | 2 |
| Ording, H | 2 |
| Wackym, PA | 1 |
| Dubrow, TJ | 1 |
| Abdul-Rasool, IH | 1 |
| Lesavoy, MA | 1 |
| Tolpin, EI | 1 |
| Michaux, K | 1 |
| Skovgaard, LT | 1 |
| Theunynck, D | 1 |
| Krivosic, I | 1 |
| Guévart, E | 1 |
| Katz, AM | 1 |
| Mulligan, PG | 1 |
5 reviews available for succinylcholine and Diathesis
| Article | Year |
|---|---|
An update on the malignant hyperthermia syndrome.
Topics: Anesthetics; Animals; Calcium; Calcium Channels; Child; Dantrolene; Disease Models, Animal; Disease | 1994 |
[Clinical features of malignant hyperthermia crisis].
Topics: Adolescent; Adult; Anesthesia, General; Arrhythmias, Cardiac; Carbon Dioxide; Child; Child, Preschoo | 1989 |
[Anesthesia in myotonia].
Topics: Anesthesia; Contracture; Disease Susceptibility; Female; Humans; Hypercapnia; Male; Malignant Hypert | 1989 |
[Screening tests for malignant hyperthermia susceptibility].
Topics: Animals; Caffeine; Calcium; Cholinesterases; Contracture; Creatine Kinase; Cyclic AMP; Disease Susce | 1989 |
Pathophysiology of malignant hyperthermia.
Topics: Animals; Calcium; Creatine Kinase; Dantrolene; Disease Susceptibility; Halothane; Humans; Lymphocyte | 1989 |
1 trial available for succinylcholine and Diathesis
| Article | Year |
|---|---|
Study of the safe threshold of apneic period in children during anesthesia induction.
Topics: Age Factors; Anesthesia, Intravenous; Anesthetics, Intravenous; Apnea; Body Height; Body Weight; Bra | 1996 |
21 other studies available for succinylcholine and Diathesis
| Article | Year |
|---|---|
Succinylcholine in malignant hyperthermia: evaluation of a novel in vivo model.
Topics: Animals; Disease Susceptibility; Female; Hemodynamics; Male; Malignant Hyperthermia; Muscle, Skeleta | 2011 |
No response to trigger agents in a malignant hyperthermia-susceptible patient.
Topics: Adult; Anesthetics, Inhalation; Body Temperature; Disease Susceptibility; Humans; Isoflurane; Male; | 2002 |
Halothane and halothane/succinylcholine induced malignant hyperthermia (porcine stress syndrome) in a population of Ontario boars.
Topics: Animals; Disease Susceptibility; Drug Combinations; Halothane; Male; Malignant Hyperthermia; Ontario | 1983 |
Suxamethonium spasm. A differential diagnostic conundrum.
Topics: Diagnosis, Differential; Disease Susceptibility; Humans; Malignant Hyperthermia; Spasm; Succinylchol | 1984 |
Failure to induce malignant hyperthermia in myotonic goats.
Topics: Animals; Disease Susceptibility; Goats; Halothane; Malignant Hyperthermia; Myotonia Congenita; Succi | 1983 |
Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation.
Topics: Animals; Base Sequence; Calcium; Calcium Channels; Disease Susceptibility; Genotype; Halothane; Hete | 1993 |
Evaluation for malignant hyperthermia susceptibility in black-tailed deer.
Topics: Anesthetics, Inhalation; Animals; Blood Gas Analysis; Cardiac Output; Deer; Disease Susceptibility; | 1996 |
Inhalation anesthetics and Duchenne's muscular dystrophy.
Topics: Anesthetics, Inhalation; Anesthetics, Intravenous; Contraindications; Disease Susceptibility; Haloth | 1999 |
Rapacuronium: an alternative to succinylcholine for electroconvulsive therapy.
Topics: Depressive Disorder; Disease Susceptibility; Electroconvulsive Therapy; Humans; Male; Malignant Hype | 2001 |
Evaluation of greyhound susceptibility to malignant hyperthermia using halothane-succinylcholine anesthesia and caffeine-halothane muscle contractures.
Topics: Anesthesia, Inhalation; Animals; Caffeine; Disease Susceptibility; Dog Diseases; Dogs; Genetic Predi | 1992 |
[The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model].
Topics: Anesthesia, Inhalation; Animals; Disease Susceptibility; Malignant Hyperthermia; Masseter Muscle; Sp | 1992 |
Effects of caffeine, halothane, succinylcholine, phenylephrine and isoproterenol on myocardial force of contraction of malignant hyperthermia susceptible swine.
Topics: Animals; Caffeine; Disease Susceptibility; Halothane; Isoproterenol; Malignant Hyperthermia; Myocard | 1991 |
Possible malignant hyperpyrexia.
Topics: Anesthesia; Child; Disease Susceptibility; Humans; Male; Malignant Hyperthermia; Succinylcholine; Th | 1990 |
Serum cholinesterase polymorphism (CHE1 and CHE2 loci) among several Indian groups from Amazon region of Brazil, and segregation of the C5 variant in families.
Topics: Alleles; Brazil; Butyrylcholinesterase; Disease Susceptibility; Female; Gene Frequency; Genetic Vari | 1989 |
Malignant hyperthermia in plastic surgery.
Topics: Adult; Caffeine; Child; Child, Preschool; Dermoid Cyst; Disease Susceptibility; Facial Neoplasms; Fe | 1988 |
Effects of anaesthetic agents on erythrocyte fragility: comparison of normal and malignant hyperthermia susceptible patients.
Topics: Disease Susceptibility; Ethanol; Halothane; Humans; In Vitro Techniques; Malignant Hyperthermia; Osm | 1987 |
In vitro diagnosis of susceptibility to malignant hyperthermia: evaluation of tests with halothane-caffeine, potassium chloride, suxamethonium and caffeine-suxamethonium.
Topics: Caffeine; Disease Susceptibility; Evaluation Studies as Topic; Halothane; Humans; In Vitro Technique | 1987 |
[Examination of the family of a patient susceptible to anesthetic malignant hyperthermia].
Topics: Adolescent; Adult; Biopsy; Disease Susceptibility; Female; Halothane; Humans; Male; Malignant Hypert | 1986 |
In vitro muscle contractures induced by halothane and suxamethonium. II: Human skeletal muscle from normal and malignant hyperthermia susceptible patients.
Topics: Disease Susceptibility; Fatty Acids, Nonesterified; Halothane; Humans; In Vitro Techniques; Indometh | 1986 |
In vitro interaction between halothane and succinylcholine in human skeletal muscle: implications for malignant hyperthermia and masseter muscle rigidity.
Topics: Caffeine; Disease Susceptibility; Drug Interactions; Halothane; Humans; In Vitro Techniques; Maligna | 1985 |
Bronchospasm induced by suxamethonium. A case report.
Topics: Bronchial Spasm; Diagnosis, Differential; Disease Susceptibility; Drug Hypersensitivity; Female; Hum | 1972 |